Your session is about to expire
← Back to Search
Dietary Supplement
Resistant Starch Diet for Chronic Kidney Disease
N/A
Waitlist Available
Led By John M Arthur, MD, Ph.D.
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults between the ages of 18 and 85 years old with glomerular filtration rate estimated by creatinine clearance (eGFR Cr) between 59 and 30 ml/min for stage 3 CKD patients and urine protein < 1 gram per day by 24-hour protein collection or urine protein-to-creatinine ratio <1 gram/gram or urine microalbumin to creatinine concentration less than 1000 mg/g.
Children between the ages of 5 and 17 years with eGFR Cr between 30 and 59 (stage 3 CKD) using the revised Schwartz equation and urine protein < 1 gram per day by 24-hour protein collection or urine protein-to-creatinine ratio <1 gram/gram.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand how diet can affect factors that slow the progression of kidney disease.
Who is the study for?
This trial is for adults aged 18-85 and children 5-17 with stage 3 chronic kidney disease (CKD), having specific levels of kidney function and protein in urine. Excluded are those under age 5 or over 85, with certain medical conditions like diabetes, recent antibiotic use, bowel diseases, past kidney transplants, pregnancy, or extreme bowel habits.
What is being tested?
The study tests if a diet supplemented with resistant starch can benefit the gut microbiome in CKD patients. It aims to see if this change improves bacterial byproducts like butyrate that might slow down CKD progression. The participants will add resistant starch to their diets for two weeks.
What are the potential side effects?
While not explicitly stated, potential side effects may include digestive changes such as bloating or gas due to increased fiber from the resistant starch.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18-85 years old with moderate kidney function and low urine protein.
Select...
I am a child aged 5-17 with moderate kidney disease and low urine protein.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage of subjects that consume at least 90% of the dietary resistant starch (RS).
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Resistant StarchExperimental Treatment1 Intervention
Intervention:
Dietary supplement will be taken every day for total of 2 weeks. Each participant will be take half the dose of Hi-Maze 260 or "High RS Gummy Chews" in the morning and the other half dose in the evening
Adult participants are asked to introduce in their diet 30 grams of high RS supplement each day of the diet period (2 weeks).
Children of age included between 5 and 9 years are asked to introduce in their diet 10 grams of high RS supplement each day of the diet period (2 weeks).
Children of age included between 10 and 17 years are asked to introduce in their diet 15 grams of high RS supplement each day of the diet period (2 weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistant Starch
2006
N/A
~140
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
496 Previous Clinical Trials
150,604 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,826 Previous Clinical Trials
8,166,454 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
297 Previous Clinical Trials
248,945 Total Patients Enrolled
John M Arthur, MD, Ph.D.Principal InvestigatorUniversity of Arkansas
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Resistant Starch
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.